How many institutions held AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in Q2 2020?

127 institutional investors reported AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value for Q2 2020. Use the holders table for investor-level position and value details.

Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

Q: What does CUSIP 05156V102 represent in this 13F holders report?

CUSIP 05156V102 is the security identifier for AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value used to aggregate holder disclosures.

CUSIP: 05156V102

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Shares, no par value
Shares outstanding: 132,929,348
Total 13F shares: 58,637,850
Share change: -1,654,166
Total reported value: $953,206,339
Put/Call ratio: 87%
Price per share: $16.25
Number of holders: 127
Value change: -$24,791,270
Number of buys: 73
Number of sells: 52

Quarterly Holders Quick Answers

What is CUSIP 05156V102?
CUSIP 05156V102 identifies AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 05156V102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
HealthCor Management, L.P.	13F	Company	7.3%	9,763,920	$141,674,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	6%	7,972,758	$115,685,000	—	31 Mar 2020	13F
Consonance Capital Management LP	13F	Company	5.2%	6,909,374	$100,255,000	—	31 Mar 2020	13F
NEA Management Company, LLC	13F	Company	3.9%	5,172,683	$75,056,000	—	31 Mar 2020	13F
Point72 Asset Management, L.P.	13F	Company	3.5%	4,669,343	$67,752,000	—	31 Mar 2020	13F
Avoro Capital Advisors LLC	13F	Company	1.3%	1,725,000	$25,030,000	—	31 Mar 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	1.3%	1,701,929	$24,695,000	—	31 Mar 2020	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	1.2%	1,615,882	$23,446,000	—	31 Mar 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.1%	1,438,800	$20,875,000	—	31 Mar 2020	13F
ORBIMED ADVISORS LLC	13F	Company	1%	1,336,547	$19,393,000	—	31 Mar 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.95%	1,259,600	$18,277,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.95%	1,258,386	$18,259,000	—	31 Mar 2020	13F
Avidity Partners Management LP	13F	Company	0.89%	1,182,000	$17,151,000	—	31 Mar 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.83%	1,098,451	$15,939,000	—	31 Mar 2020	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.81%	1,077,570	$15,653,000	—	31 Mar 2020	13F
Assenagon Asset Management S.A.	13F	Company	0.75%	998,844	$14,493,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	0.7%	931,513	$13,516,000	—	31 Mar 2020	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.58%	770,000	$11,173,000	—	31 Mar 2020	13F
Artal Group S.A.	13F	Company	0.56%	750,000	$10,883,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.46%	610,282	$8,855,000	—	31 Mar 2020	13F
Vivo Capital, LLC	13F	Company	0.38%	500,732	$7,266,000	—	31 Mar 2020	13F
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F	Company	0.35%	462,680	$6,713,000	—	31 Mar 2020	13F
Atom Investors LP	13F	Company	0.33%	441,303	$6,403,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.31%	415,853	$6,034,000	—	31 Mar 2020	13F
Hudson Bay Capital Management LP	13F	Company	0.31%	410,000	$5,949,000	—	31 Mar 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.31%	408,096	$5,921,000	—	31 Mar 2020	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.3%	400,000	$5,804,000	—	31 Mar 2020	13F
Ghost Tree Capital, LLC	13F	Company	0.3%	400,000	$5,804,000	—	31 Mar 2020	13F
LORD, ABBETT & CO. LLC	13F	Company	0.24%	321,458	$4,665,000	—	31 Mar 2020	13F
Allianz Asset Management GmbH	13F	Company	0.18%	235,265	$3,377,000	—	31 Mar 2020	13F
Ikarian Capital, LLC	13F	Company	0.16%	218,771	$3,174,000	—	31 Mar 2020	13F
GROUP ONE TRADING LLC	13F	Company	0.16%	218,274	$3,167,000	—	31 Mar 2020	13F
Burrage Capital Management LLC	13F	Company	0.15%	196,438	$2,901,000	—	31 Mar 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.15%	192,853	$2,798,000	—	31 Mar 2020	13F
TD ASSET MANAGEMENT INC	13F	Company	0.13%	178,096	$2,556,000	—	31 Mar 2020	13F
Global IMC LLC	13F	Company	0.12%	157,128	$2,280,000	—	31 Mar 2020	13F
Swiss National Bank	13F	Company	0.12%	157,400	$2,244,000	—	31 Mar 2020	13F
J. Goldman & Co LP	13F	Company	0.11%	147,614	$2,142,000	—	31 Mar 2020	13F
IRONWOOD INVESTMENT MANAGEMENT LLC	13F	Company	0.11%	146,697	$2,129,000	—	31 Mar 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.09%	122,638	$1,779,000	—	31 Mar 2020	13F
UBS Group AG	13F	Company	0.09%	122,402	$1,776,000	—	31 Mar 2020	13F
Parkman Healthcare Partners LLC	13F	Company	0.09%	120,288	$1,745,000	—	31 Mar 2020	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.07%	98,913	$1,435,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	0.07%	97,146	$1,410,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.07%	95,963	$1,391,000	—	31 Mar 2020	13F
Rockefeller Capital Management L.P.	13F	Company	0.07%	93,085	$1,351,000	—	31 Mar 2020	13F
Tekla Capital Management LLC	13F	Company	0.07%	90,788	$1,317,000	—	31 Mar 2020	13F
Man Group plc	13F	Company	0.06%	83,588	$1,213,000	—	31 Mar 2020	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	0.06%	80,800	$1,172,000	—	31 Mar 2020	13F
BARCLAYS PLC	13F	Company	0.06%	77,686	$1,127,000	—	31 Mar 2020	13F

Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q2 2020

As of 30 Jun 2020, Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by 127 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 58,637,850 shares. The largest 10 holders included HealthCor Management, L.P., FMR LLC, NEA Management Company, LLC, Consonance Capital Management LP, Point72 Asset Management, L.P., Avidity Partners Management LP, PICTET ASSET MANAGEMENT LTD, BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, and Connor, Clark & Lunn Investment Management Ltd.. This page lists 127 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

122

Q2 2020 holders

127

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.